Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Matinas Biopharma Holdings - 11 Year Stock Price History | MTNB

Historical daily share price chart and data for Matinas Biopharma Holdings since 2014 adjusted for splits and dividends. The latest closing stock price for Matinas Biopharma Holdings as of June 27, 2025 is 0.92.
  • The all-time high Matinas Biopharma Holdings stock closing price was 194.00 on March 06, 2017.
  • The Matinas Biopharma Holdings 52-week high stock price is 4.49, which is 388% above the current share price.
  • The Matinas Biopharma Holdings 52-week low stock price is 0.09, which is 90.2% below the current share price.
  • The average Matinas Biopharma Holdings stock price for the last 52 weeks is 1.04.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Matinas Biopharma Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.6617 0.5880 1.0400 0.5127 0.9201 80.41%
2024 7.1522 11.2500 18.4900 0.5100 0.5100 -95.28%
2023 17.9861 26.6500 35.7500 6.1300 10.8100 -56.76%
2022 36.8686 53.0000 53.0000 23.2500 25.0000 -50.50%
2021 51.5171 87.0000 87.0000 33.5100 50.5000 -25.74%
2020 46.1166 115.5000 115.5000 26.0500 68.0000 -40.09%
2019 48.9448 30.5000 113.5000 29.4400 113.5000 281.51%
2018 35.4568 62.0000 66.0000 17.6500 29.7500 -48.71%
2017 100.5207 74.5000 194.0000 52.5000 58.0000 -17.14%
2016 46.3117 44.7500 97.5000 22.2500 70.0000 64.71%
2015 40.8024 22.5000 71.0000 16.7500 42.5000 88.89%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.001B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.719B 32.53
Zoetis (ZTS) United States $69.528B 25.94
Takeda Pharmaceutical (TAK) Japan $48.047B 9.56
Daiichi Sankyo, - (DSNKY) Japan $43.343B 22.21
BeOne Medicines - (ONC) Cayman Islands $26.436B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.802B 0.00
Merck (MKKGY) Germany $17.015B 12.47
Summit Therapeutics (SMMT) United States $15.299B 0.00
Shionogi (SGIOY) Japan $14.887B 14.91
United Therapeutics (UTHR) United States $12.823B 11.34
Neurocrine Biosciences (NBIX) United States $12.412B 42.52
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.765B 63.12
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.678B 0.00
Ionis Pharmaceuticals (IONS) United States $6.335B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.092B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.195B 0.00
Hypermarcas (HYPMY) Brazil $3.072B 20.21
Crinetics Pharmaceuticals (CRNX) United States $2.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.657B 9.31
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.085B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.959B 0.00
ARS Pharmaceuticals (SPRY) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.754B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.469B 0.00
Guardian Pharmacy Services (GRDN) United States $1.353B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.167B 23.35
Harrow (HROW) United States $1.133B 0.00
Dyne Therapeutics (DYN) United States $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.015B 0.00
Verve Therapeutics (VERV) United States $1.007B 0.00
Collegium Pharmaceutical (COLL) United States $0.962B 5.19
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.890B 0.00
Ardelyx (ARDX) United States $0.883B 0.00
Elite Pharmaceuticals (ELTP) United States $0.760B 0.00
Xeris Biopharma Holdings (XERS) United States $0.735B 0.00
Cronos Group (CRON) Canada $0.733B 0.00
USANA Health Sciences (USNA) United States $0.580B 12.60
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Bioventus (BVS) United States $0.556B 14.10
Zevra Therapeutics (ZVRA) United States $0.492B 0.00
AleAnna (ANNA) United States $0.481B 0.00
Organogenesis (ORGO) United States $0.466B 0.00
Siga Technologies (SIGA) United States $0.462B 9.64
Tourmaline Bio (TRML) United States $0.425B 0.00
Oruka Therapeutics (ORKA) United States $0.415B 0.00
Savara (SVRA) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 9.41
Heron Therapeutics (HRTX) United States $0.326B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nektar Therapeutics (NKTR) United States $0.320B 0.00
Altimmune (ALT) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.268B 24.58
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
Liminatus Pharma (LIMN) United States $0.247B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.213B 0.00
MediWound (MDWD) Israel $0.208B 0.00
OmniAb (OABI) United States $0.208B 0.00
Esperion Therapeutics (ESPR) United States $0.197B 0.00
ProKidney (PROK) United States $0.196B 0.00
Larimar Therapeutics (LRMR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Galectin Therapeutics (GALT) United States $0.147B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Korro Bio (KRRO) United States $0.113B 0.00
VAXART, INC (VXRT) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.107B 17.64
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Unicycive Therapeutics (UNCY) United States $0.086B 0.00
Cassava Sciences (SAVA) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Achieve Life Sciences (ACHV) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.039B 28.89
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.17
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Crescent Biopharma (CBIO) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.16
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00